Evidence map›Paper›PMID 41874480›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Studying Macromolecular Composition in Cell-Cell Interfaces Using 3D Membrane Reconstitution Systems.

Franziska Ragaller, Amelie Maribel Schneider, Ellen Sjule, Renhua Sun, Xiao Han, Luca Andronico, Edward Jenkins, Michael Dustin, Adnane Achour, Erdinc Sezgin

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Franziska RagallerScience for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.ORCID https://orcid.org/0000-0002-4148-262X
Amelie Maribel SchneiderScience for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.
Ellen SjuleScience for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.
Renhua SunScience for Life Laboratory, Department of Medicine, Karolinska Institute & Division of Infectious Diseases, Karolinska University Hospital, Solna, Sweden.
Xiao HanScience for Life Laboratory, Department of Medicine, Karolinska Institute & Division of Infectious Diseases, Karolinska University Hospital, Solna, Sweden.
Luca AndronicoScience for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.ORCID https://orcid.org/0000-0002-4326-073X
Edward JenkinsKennedy Institute of Rheumatology, NDORMS, University of Oxford, Oxford, UK.
Michael DustinKennedy Institute of Rheumatology, NDORMS, University of Oxford, Oxford, UK.
Adnane AchourScience for Life Laboratory, Department of Medicine, Karolinska Institute & Division of Infectious Diseases, Karolinska University Hospital, Solna, Sweden.
Erdinc SezginScience for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.ORCID https://orcid.org/0000-0002-4915-388X

Funding

Cancerfonden 24 3775 PjCancer Research KI 2024-03488ES is an EMBO Young Investigator YIP-2025Human Frontier Science Program RGP0025/2022Insamlingsstiftelsen Cancer- och Allergifonden 244092Radiumhemmets Forskningsfonder 244092SciLifeLab Advanced Light Microscopy facility and National Microscopy Infrastructure VR-RFI 2016-00968Swedish Research Council 2020-02682Swedish Research Council 2024-00289Swedish Research Council 2024-02993Wellcome Leap's Dynamic Resilience Program (jointly funded by Temasek Trust), Karolinska Institutet 2020-00997Wellcome Leap's Dynamic Resilience Program (jointly funded by Temasek Trust), Karolinska Institutet 2022-00803Wellcome Leap's Dynamic Resilience Program (jointly funded by Temasek Trust), Karolinska Institutet 2024-03250Wellcome Leap's Dynamic Resilience Program (jointly funded by Temasek Trust), Karolinska Institutet 2024-03341Wellcome Trust
6 · The paper itself

Abstract

During direct communication between two cells, the plasma membranes of each cell serve as a platform for ligand-receptor interaction initiating downstream signaling cascades. In immune cell signaling, this cell-cell interface - the immune synapse - is highly spatiotemporally organized. Multiple stimulatory and co-stimulatory signals need to be integrated over time to ensure proper immune cell function. This process is still not fully understood given the vast complexity of interactions between proteins, lipids, glycocalyx and associated cortical actin cytoskeleton. Here, we presented a fully artificial model system to study the interface between two vesicles and a semi-artificial one between a live cell and a vesicle to reconstitute 3D contacts. We investigated the distribution and reorganization of immune cell proteins at artificial and semi-artificial contacts. We show the enrichment and depletion of different proteins in the synapse and how different peptides with varying affinity presented by the same MHC class I affect T cell activation. We further explored the distribution of glycocalyx elements and showed differential partitioning of different sugar moieties in the interface. While we focused on the T cell interface here, our model systems are powerful tools to study the distribution and reorganization of lipids, proteins and glycocalyx components at any cell-cell contact.

Indexed as

Cell CommunicationCell MembraneGlycocalyxImmunological SynapsesMacromolecular SubstancesT-LymphocytesAnimalsHumansLymphocyte ActivationSignal TransductionMacromolecular Substances

Identifiers

PMID41874480
PMCPMC13588059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.